摘要
目的观察复方萘普生栓配伍米索前列醇片应用于剖宫产术后宫内节育器放置术的临床效果。方法选取放置宫内节育器的妇女200例随机分成两组,观察组于宫内节育器放置术前1小时阴道内放置米索前列醇粉,并于术前30分钟肛门内放置复方萘普生栓1粒,对照组术前不用任何药物。对所得数据进行统计分析。结果观察组宫颈扩张情况、术中手术时间和发生心脑综合征情况与对照组比较,差异有统计学意义(P<0.05)。结论剖宫产术后妇女宫内节育器放置术前应用复方萘普生栓及米索前列醇片有利于手术操作,缩短手术时间,减少痛苦或无痛苦,减低手术并发症,临床效果显著,值得临床推广。
Objective To observe the clinical effect of compound naproxen suppositories with misoprostol tablets in the use of insertion of intrauterine contraceptive device after cesarean section. Methods 200 women with insertion of intrauterine contraceptive devices were randomized into two groups. The observation group received misoprostol into the uterus an hour before the operation, and a tablet of compound naproxen suppositories into the anus 30 minutes before the surgery. The control group received no medicine. The data of two groups were compared. Results Compared with the control group, the difference of cervical dilatation, operative time and occurrence of cardio-cerebral syndrome was statistically significant (P 〈0.05). Conclusions It is useful for operation to apply compound naproxen suppositories and misoprostol between caesarean section and putting the birth control machine into the uterus. It also can shorten the time of surgery with reducing or no pain and reduce the operative complications. The clinical effect is remarkable and worth spreading.
出处
《临床医学工程》
2013年第1期27-28,共2页
Clinical Medicine & Engineering
基金
广东省人口和计划生育委员会科研项目(项目编号:20110309)
关键词
宫内节育器放置术
米索前列醇片
复方萘普生栓
宫颈扩张
Insertion of intrauterine contraceptive device
Misoprostol tablet
Compound naproxen suppository
Cervical dilatation